Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Digital Diabetes Management Market, by Type
1.4.2 Europe Digital Diabetes Management Market, by Product & Service
1.4.3 Europe Digital Diabetes Management Market, by End User
1.4.4 Europe Digital Diabetes Management Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Business Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2018, Jun – 2022, Apr) Leading Players
Chapter 4. Europe Digital Diabetes Management Market by Type
4.1 Europe Wearables Market by Country
4.2 Europe Handheld Devices Market by Country
Chapter 5. Europe Digital Diabetes Management Market by Product & Service
5.1 Europe Devices Market by Country
5.2 Europe Digital Diabetes Management Market by Devices Type
5.2.1 Europe Continuous Glucose Monitoring (CGM) Systems Market by Country
5.2.2 Europe Smart Glucose Meters Market by Country
5.2.3 Europe Smart Insulin Pens Market by Country
5.2.4 Europe Smart Insulin Pumps/Closed-loop Pumps & Smart Insulin Patches Market by Country
5.3 Europe Application Market by Country
5.4 Europe Digital Diabetes Management Market by Application Type
5.4.1 Europe Diabetes & Blood Glucose Tracking Apps Market by Country
5.4.2 Europe Obesity & Diet Management Apps Market by Country
5.5 Europe Data Management Software & Platforms Market by Country
5.6 Europe Services Market by Country
Chapter 6. Europe Digital Diabetes Management Market by End User
6.1 Europe Self/Home Healthcare Market by Country
6.2 Europe Hospitals & Specialty Diabetes Clinics Market by Country
6.3 Europe Academic & Research Institutes Market by Country
Chapter 7. Europe Digital Diabetes Management Market by Country
7.1 Germany Digital Diabetes Management Market
7.1.1 Germany Digital Diabetes Management Market by Type
7.1.2 Germany Digital Diabetes Management Market by Product & Service
7.1.2.1 Germany Digital Diabetes Management Market by Devices Type
7.1.2.2 Germany Digital Diabetes Management Market by Application Type
7.1.3 Germany Digital Diabetes Management Market by End User
7.2 UK Digital Diabetes Management Market
7.2.1 UK Digital Diabetes Management Market by Type
7.2.2 UK Digital Diabetes Management Market by Product & Service
7.2.2.1 UK Digital Diabetes Management Market by Devices Type
7.2.2.2 UK Digital Diabetes Management Market by Application Type
7.2.3 UK Digital Diabetes Management Market by End User
7.3 France Digital Diabetes Management Market
7.3.1 France Digital Diabetes Management Market by Type
7.3.2 France Digital Diabetes Management Market by Product & Service
7.3.2.1 France Digital Diabetes Management Market by Devices Type
7.3.2.2 France Digital Diabetes Management Market by Application Type
7.3.3 France Digital Diabetes Management Market by End User
7.4 Russia Digital Diabetes Management Market
7.4.1 Russia Digital Diabetes Management Market by Type
7.4.2 Russia Digital Diabetes Management Market by Product & Service
7.4.2.1 Russia Digital Diabetes Management Market by Devices Type
7.4.2.2 Russia Digital Diabetes Management Market by Application Type
7.4.3 Russia Digital Diabetes Management Market by End User
7.5 Spain Digital Diabetes Management Market
7.5.1 Spain Digital Diabetes Management Market by Type
7.5.2 Spain Digital Diabetes Management Market by Product & Service
7.5.2.1 Spain Digital Diabetes Management Market by Devices Type
7.5.2.2 Spain Digital Diabetes Management Market by Application Type
7.5.3 Spain Digital Diabetes Management Market by End User
7.6 Italy Digital Diabetes Management Market
7.6.1 Italy Digital Diabetes Management Market by Type
7.6.2 Italy Digital Diabetes Management Market by Product & Service
7.6.2.1 Italy Digital Diabetes Management Market by Devices Type
7.6.2.2 Italy Digital Diabetes Management Market by Application Type
7.6.3 Italy Digital Diabetes Management Market by End User
7.7 Rest of Europe Digital Diabetes Management Market
7.7.1 Rest of Europe Digital Diabetes Management Market by Type
7.7.2 Rest of Europe Digital Diabetes Management Market by Product & Service
7.7.2.1 Rest of Europe Digital Diabetes Management Market by Devices Type
7.7.2.2 Rest of Europe Digital Diabetes Management Market by Application Type
7.7.3 Rest of Europe Digital Diabetes Management Market by End User
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.5.4 Business Expansions:
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Approvals and Trials:
8.3 Terumo Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Partnerships, Collaborations, and Agreements:
8.4 F. Hoffmann-La Roche Ltd.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.5 DexCom, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.6 Novo Nordisk A/S
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental & Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.7 ACON Laboratories, Inc.
8.7.1 Company Overview
8.8 Bayer AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 B. Braun Melsungen AG
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.10. Azumio, Inc.
8.10.1 Company Overview
Unique Offerings 